1 results match your criteria: "Parkinson School of Health Sciences and Public Health (Dr. Adams)[Affiliation]"
One Dose Versus Two Doses of Intravenous Tranexamic Acid in Total Joint Arthroplasty.
J Am Acad Orthop Surg
June 2021
From the Department of Orthopaedic Surgery and Rehabilitation, Loyola University Medical Center Stritch School of Medicine (Dr. Golz, Ms. Yee, Dr. Davis, and Dr. Brown), and the Department of Public Health Sciences, Loyola University Medical Center, Parkinson School of Health Sciences and Public Health (Dr. Adams), Maywood, IL.
Introduction: Despite its widespread use, a single formulation or dosing regimen of tranexamic acid (TXA) has not been universally agreed on for total joint arthroplasty. The purpose of this study is to compare previously uninvestigated single-dose and two-dose regimens in postoperative hemoglobin level and secondary outcomes within 30 days of surgery.
Methods: A retrospective search of our institution's database of patients who underwent primary total knee arthroplasty and primary total hip arthroplasty between January 1, 2017, and July 1, 2019, was performed.